Comparing the Fracture Profile of Osteosarcopenic Older Adults with Osteopenia/Osteoporosis Alone.


Journal

Calcified tissue international
ISSN: 1432-0827
Titre abrégé: Calcif Tissue Int
Pays: United States
ID NLM: 7905481

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 05 07 2022
accepted: 13 11 2022
pubmed: 28 11 2022
medline: 3 3 2023
entrez: 27 11 2022
Statut: ppublish

Résumé

To determine whether osteosarcopenia is associated with a greater likelihood of recurrent fractures, as well as type of fracture, than osteopenia/osteoporosis or sarcopenia alone. Anthropometry (height/weight; scales and stadiometer), body composition (bone mineral density [BMD] and appendicular lean mass; dual-energy x-ray absorptiometry), grip strength (hydraulic dynamometer), and gait speed (4 m) were measured in an outpatient clinic. WHO definition for osteopenia/osteoporosis (BMD T-score below -1 SDs) while sarcopenia was defined by SDOC or EWGSOP2. Number and location of fractures within the past 5 years were self-reported and verified by medical records (unverified fractures excluded). Univariable and multivariable regressions were used to examine the association between the exposure and outcome while adjusting for confounders. 481 community-dwelling older adults (median age: 78, IQR: 72, 83; 75.9% women) were included. Prevalence of osteosarcopenia depended on the definition (SDOC: 179 (37.2%); EWGSOP2: 123 (25.6%)). In multivariable analysis adjusting for age, sex, alcohol, smoking, BMI, lowest BMD T-score, physical activity, and comorbidities, the likelihood of recurrent fractures (≥ 2 vs 0-1) was significantly higher in those with osteosarcopenia versus osteopenia/osteoporosis irrespective of the definition (SDOC: odds ratio [OR]: 1.63, 95% CI: 1.03, 2.59, p = 0.037; EWGSOP2: OR: 1.83, 95% CI: 1.12, 3.01, p = 0.016]. Associations with sarcopenia alone (SDOC: 10; EWGSOP2: 7) were not possible due to the extremely low prevalence of this condition in those with normal BMD. Our data suggest osteosarcopenia is associated with a greater likelihood of recurrent fractures versus osteopenia/osteoporosis alone. Further studies are needed to evaluate the relationship with sarcopenia alone.

Identifiants

pubmed: 36436030
doi: 10.1007/s00223-022-01044-1
pii: 10.1007/s00223-022-01044-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

297-307

Subventions

Organisme : Australian Institute for Musculoskeletal Science
ID : Seed Grant

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Kirk B, Zanker J, Duque G (2020) Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers. J Cachexia Sarcopenia Muscle 11(3):609–618. https://doi.org/10.1002/jcsm.12567
doi: 10.1002/jcsm.12567 pubmed: 32202056 pmcid: 7296259
Kirk B et al (2020) A clinical guide to the pathophysiology, diagnosis and treatment of osteosarcopenia. Maturitas 140:27–33. https://doi.org/10.1016/j.maturitas.2020.05.012
doi: 10.1016/j.maturitas.2020.05.012 pubmed: 32972632
Kirk B et al (2020) Muscle, bone, and fat crosstalk: the biological role of myokines, osteokines, and adipokines. Curr Osteoporos Rep 18(4):388–400. https://doi.org/10.1007/s11914-020-00599-y
doi: 10.1007/s11914-020-00599-y pubmed: 32529456
Teng Z et al (2021) The analysis of osteosarcopenia as a risk factor for fractures, mortality, and falls. Osteoporos Int 32(11):2173–2183. https://doi.org/10.1007/s00198-021-05963-x
doi: 10.1007/s00198-021-05963-x pubmed: 33877382
Balogun S et al (2019) Prospective associations of osteosarcopenia and osteodynapenia with incident fracture and mortality over 10 years in community-dwelling older adults. Arch Gerontol Geriatr 82:67–73. https://doi.org/10.1016/j.archger.2019.01.015
doi: 10.1016/j.archger.2019.01.015 pubmed: 30716680
Chalhoub D et al (2015) Risk of nonspine fractures in older adults with sarcopenia, low bone mass, or both. J Am Geriatr Soc 63(9):1733–1740. https://doi.org/10.1111/jgs.13605
doi: 10.1111/jgs.13605 pubmed: 26310882 pmcid: 4625906
Scott D et al (2019) Does combined osteopenia/osteoporosis and sarcopenia confer greater risk of falls and fracture than either condition alone in older men? The concord health and ageing in men project. J Gerontol A Biol Sci Med Sci 74(6):827–834. https://doi.org/10.1093/gerona/gly162
doi: 10.1093/gerona/gly162 pubmed: 30032209
Salech F et al (2021) Osteosarcopenia predicts falls, fractures, and mortality in Chilean community-dwelling older adults. J Am Med Dir Assoc 22(4):853–858. https://doi.org/10.1016/j.jamda.2020.07.032
doi: 10.1016/j.jamda.2020.07.032 pubmed: 32921573
Kanis JA et al (2008) A reference standard for the description of osteoporosis. Bone 42(3):467–475. https://doi.org/10.1016/j.bone.2007.11.001
doi: 10.1016/j.bone.2007.11.001 pubmed: 18180210
Harvey NC et al (2021) Sarcopenia definitions as predictors of fracture risk independent of FRAX(®), falls, and BMD in the osteoporotic fractures in Men (MrOS) study: a meta-analysis. J Bone Miner Res 36(7):1235–1244. https://doi.org/10.1002/jbmr.4293
doi: 10.1002/jbmr.4293 pubmed: 33831257
Kirk B et al (2020) Associations between osteoporosis, the severity of sarcopenia and fragility fractures in community-dwelling older adults. Eur Geriatr Med 11(3):443–450. https://doi.org/10.1007/s41999-020-00301-6
doi: 10.1007/s41999-020-00301-6 pubmed: 32297263
Kirk B et al (2021) Sarcopenia definitions and outcomes consortium (SDOC) criteria are strongly associated with malnutrition, depression, falls, and fractures in high-risk older persons. J Am Med Dir Assoc 22(4):741–745. https://doi.org/10.1016/j.jamda.2020.06.050
doi: 10.1016/j.jamda.2020.06.050 pubmed: 32771358
Cosman F et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381. https://doi.org/10.1007/s00198-014-2794-2
doi: 10.1007/s00198-014-2794-2 pubmed: 25182228 pmcid: 4176573
Charlson ME et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383
doi: 10.1016/0021-9681(87)90171-8 pubmed: 3558716
Bhasin S et al (2020) Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium. J Am Geriatr Soc 68(7):1410–1418
doi: 10.1111/jgs.16372 pubmed: 32150289
Cruz-Jentoft AJ et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31. https://doi.org/10.1093/ageing/afy169
doi: 10.1093/ageing/afy169 pubmed: 30312372
Organization WH (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group [meeting held in Rome from 22 to 25 June 1992]. World Health Organization
Eisman J et al (2010) Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men. Australian Col Gen Pract, South Melbourne, pp 1–76
Riggs BL, Melton L III (1995) The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17(5):S505–S511
doi: 10.1016/8756-3282(95)00258-4
Kirk B, Salech F, Duque G (2020) Fall prevention in community-dwelling older adults. N Engl J Med 382(26):2581. https://doi.org/10.1056/NEJMc2005662
doi: 10.1056/NEJMc2005662 pubmed: 32579830
Harvey NC et al (2018) Measures of physical performance and muscle strength as predictors of fracture risk independent of FRAX, falls, and aBMD: a meta-analysis of the osteoporotic fractures in men (MrOS) study. J Bone Miner Res 33(12):2150–2157. https://doi.org/10.1002/jbmr.3556
doi: 10.1002/jbmr.3556 pubmed: 30011086
Harvey NC et al (2021) Predictive value of DXA appendicular lean mass for incident fractures, falls, and mortality, independent of prior falls, FRAX, and BMD: findings from the women’s health initiative (WHI). J Bone Miner Res 36(4):654–661. https://doi.org/10.1002/jbmr.4239
doi: 10.1002/jbmr.4239 pubmed: 33450071
Cawthon PM et al (2020) Putative cut-points in sarcopenia components and incident adverse health outcomes: an SDOC analysis. J Am Geriatr Soc 68(7):1429–1437. https://doi.org/10.1111/jgs.16517
doi: 10.1111/jgs.16517 pubmed: 32633824 pmcid: 7508260
Perez-Sousa MA et al (2019) Gait speed as a mediator of the effect of sarcopenia on dependency in activities of daily living. J Cachexia Sarcopenia Muscle 10(5):1009–1015. https://doi.org/10.1002/jcsm.12444
doi: 10.1002/jcsm.12444 pubmed: 31066999 pmcid: 6818451
Cawthon PM et al (2021) Muscle mass assessed by the d3-creatine dilution method and incident self-reported disability and mortality in a prospective observational study of community-dwelling older men. J Gerontol A Biol Sci Med Sci 76(1):123–130. https://doi.org/10.1093/gerona/glaa111
doi: 10.1093/gerona/glaa111 pubmed: 32442245
Cawthon PM et al (2022) Association between muscle mass determined by D(3) -creatine dilution and incident fractures in a prospective cohort study of older men. J Bone Miner Res. https://doi.org/10.1002/jbmr.4505
doi: 10.1002/jbmr.4505 pubmed: 35689796
Cawthon PM et al (2019) Strong relation between muscle mass determined by D3-creatine dilution, physical performance, and incidence of falls and mobility limitations in a prospective cohort of older men. J Gerontol A Biol Sci Med Sci 74(6):844–852. https://doi.org/10.1093/gerona/gly129
doi: 10.1093/gerona/gly129 pubmed: 29897420

Auteurs

Ben Kirk (B)

Department of Medicine, Melbourne Medical School, University of Melbourne, Western Health, St Albans, Melbourne, VIC, Australia.
Australian Institute for Musculoskeletal Science (AIMSS), University of Melbourne and Western Health, St Albans, Melbourne, VIC, Australia.

Simon Zhang (S)

Department of Medicine, Melbourne Medical School, University of Melbourne, Western Health, St Albans, Melbourne, VIC, Australia.
Australian Institute for Musculoskeletal Science (AIMSS), University of Melbourne and Western Health, St Albans, Melbourne, VIC, Australia.

Sara Vogrin (S)

Department of Medicine, Melbourne Medical School, University of Melbourne, Western Health, St Albans, Melbourne, VIC, Australia.
Australian Institute for Musculoskeletal Science (AIMSS), University of Melbourne and Western Health, St Albans, Melbourne, VIC, Australia.

Christel Harijanto (C)

Department of Medicine, Melbourne Medical School, University of Melbourne, Western Health, St Albans, Melbourne, VIC, Australia.
Australian Institute for Musculoskeletal Science (AIMSS), University of Melbourne and Western Health, St Albans, Melbourne, VIC, Australia.

Myrla Sales (M)

Department of Medicine, Melbourne Medical School, University of Melbourne, Western Health, St Albans, Melbourne, VIC, Australia.
Australian Institute for Musculoskeletal Science (AIMSS), University of Melbourne and Western Health, St Albans, Melbourne, VIC, Australia.

Gustavo Duque (G)

Department of Medicine, Melbourne Medical School, University of Melbourne, Western Health, St Albans, Melbourne, VIC, Australia. gustavo.duque@mcgill.ca.
Australian Institute for Musculoskeletal Science (AIMSS), University of Melbourne and Western Health, St Albans, Melbourne, VIC, Australia. gustavo.duque@mcgill.ca.
Department of Medicine and Research Institute, McGill University Health Centre, 1001 Decarie Boulevard, Montreal, QC, H4A 3J1, Canada. gustavo.duque@mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH